Market Place
Sourcing Support
Cardurion Pharma Appoints Charlotte as Chief Business Officer
08 Jan 2025 //
BUSINESSWIRE
Cardurion Pharmaceuticals Selected As Endpoints 11 Company
27 Sep 2024 //
BUSINESSWIRE
Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors
26 Sep 2024 //
BUSINESSWIRE
Cardurion Pharma Raises $260M Series B For Cardiovascular Pipeline
16 Jul 2024 //
BUSINESSWIRE
Cardio-focused Cardurion raises hearty $260M series B
16 Jul 2024 //
FIERCE BIOTECH
Cardurion Positive PDE9 Inhibitor Heart Failure Data
11 May 2024 //
BUSINESSWIRE
Cardurion to Present at the 42nd Annual J.P. Morgan Healthcare Conference
05 Jan 2024 //
BUSINESSWIRE
Cardurion Pharmaceuticals to Provide Update on CaMKII Inhibitor Program
07 Nov 2023 //
BUSINESSWIRE
Cardurion Welcomes Emma Reeve as Independent Board Director and Audit Chair
04 Oct 2023 //
BUSINESSWIRE
Cardurion Appoints Elizabeth Radcliffe as Chief Financial Officer
19 Jan 2023 //
BUSINESSWIRE
Cardurion Pharma Announces Dosing of Patients in CARDINAL-HF, PII Trial
19 Jul 2022 //
BUSINESSWIRE
Cardurion Pharma Enhances Leadership Team, Appoints Marcia Moore as COO
16 Feb 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.